WallStSmart

Zebra Technologies Corporation (ZBRA)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zebra Technologies Corporation generates 1984% more annual revenue ($5.40B vs $258.90M). ZBRA leads profitability with a 7.8% profit margin vs -15.5%. ZBRA earns a higher WallStSmart Score of 58/100 (C).

ZBRA

Buy

58

out of 100

Grade: C

Growth: 3.3Profit: 6.0Value: 7.3Quality: 5.8
Piotroski: 2/9Altman Z: 2.46

ZEPP

Hold

38

out of 100

Grade: F

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ZBRAUndervalued (+10.5%)

Margin of Safety

+10.5%

Fair Value

$281.98

Current Price

$229.76

$52.22 discount

UndervaluedFair: $281.98Overvalued
ZEPPUndervalued (+48.9%)

Margin of Safety

+48.9%

Fair Value

$46.96

Current Price

$18.01

$28.95 discount

UndervaluedFair: $46.96Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ZBRA1 strengths · Avg: 10.0/10
PEG RatioValuation
0.4810/10

Growing faster than its price suggests

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

ZBRA4 concerns · Avg: 3.0/10
P/E RatioValuation
27.8x4/10

Moderate valuation

Profit MarginProfitability
7.8%3/10

7.8% margin — thin

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

EPS GrowthGrowth
-55.8%2/10

Earnings declined 55.8%

ZEPP4 concerns · Avg: 2.3/10
Market CapQuality
$270.28M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Free Cash FlowQuality
$-26.48M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : ZBRA

The strongest argument for ZBRA centers on PEG Ratio. Revenue growth of 10.6% demonstrates continued momentum. PEG of 0.48 suggests the stock is reasonably priced for its growth.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : ZBRA

The primary concerns for ZBRA are P/E Ratio, Profit Margin, Piotroski F-Score.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

ZBRA profiles as a value stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

ZBRA generates stronger free cash flow (327M), providing more financial flexibility.

Bottom Line

ZBRA scores higher overall (58/100 vs 38/100) and 10.6% revenue growth. ZEPP offers better value entry with a 48.9% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Zebra Technologies Corporation

TECHNOLOGY · COMMUNICATION EQUIPMENT · USA

Zebra Technologies Corporation is an American company that manufactures and sells marking, tracking, and computer printing technologies. Its products include thermal barcode label and receipt printers, RFID smart label printers/encoders/fixed & handheld readers/antennas, and card and kiosk printers that are used for barcode labeling, personal identification, and specialty printing, principally in the manufacturing, supply chain, retail, healthcare, and government sectors.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?